These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21704908)

  • 1. Functional validation confirms genomic phenotypes of glioblastoma with implications for targeted therapy.
    Parsa AT
    World Neurosurg; 2011; 75(5-6):573-4. PubMed ID: 21704908
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytogenetic and molecular genetic study on granular cell glioblastoma: a case report.
    Joo M; Park SH; Chang SH; Kim H; Choi CY; Lee CH; Lee BH; Hwang YJ
    Hum Pathol; 2013 Feb; 44(2):282-8. PubMed ID: 23058249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecularly targeted therapies for recurrent glioblastoma: current and future targets.
    Lau D; Magill ST; Aghi MK
    Neurosurg Focus; 2014 Dec; 37(6):E15. PubMed ID: 25434384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal diversity in glioblastoma: is it clinically relevant?
    Watts C; Piccirillo SG
    Future Oncol; 2015; 11(12):1703-6. PubMed ID: 26075436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.
    Snuderl M; Fazlollahi L; Le LP; Nitta M; Zhelyazkova BH; Davidson CJ; Akhavanfard S; Cahill DP; Aldape KD; Betensky RA; Louis DN; Iafrate AJ
    Cancer Cell; 2011 Dec; 20(6):810-7. PubMed ID: 22137795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [p16 tumor suppressor gene alteration in brain tumors].
    Kumanishi T
    No To Shinkei; 1998 Jun; 50(6):511-7. PubMed ID: 9656246
    [No Abstract]   [Full Text] [Related]  

  • 7. MRI study identifies three subtypes of glioblastoma.
    Brower V
    Lancet Oncol; 2015 Oct; 16(13):e484. PubMed ID: 26365415
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges.
    Nicholas MK; Lukas RV; Chmura S; Yamini B; Lesniak M; Pytel P
    Semin Oncol; 2011 Apr; 38(2):243-53. PubMed ID: 21421114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments.
    Kesari S
    Semin Oncol; 2011 Dec; 38 Suppl 4():S2-10. PubMed ID: 22078644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
    Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN
    J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SnapShot: glioblastoma multiforme.
    Kotliarova S; Fine HA
    Cancer Cell; 2012 May; 21(5):710-710.e1. PubMed ID: 22624719
    [No Abstract]   [Full Text] [Related]  

  • 12. 5' CpG island methylation of p16 is associated with absence of p16 expression in glioblastomas.
    Park SH; Jung KC; Ro JY; Kang GH; Khang SK
    J Korean Med Sci; 2000 Oct; 15(5):555-9. PubMed ID: 11068994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomics illuminates a deadly brain cancer.
    Kuehn BM
    JAMA; 2010 Mar; 303(10):925-7. PubMed ID: 20215599
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular and clinical analysis of glioblastoma with an oligodendroglial component (GBMO).
    Nakamura H; Makino K; Kuratsu J
    Brain Tumor Pathol; 2011 Jul; 28(3):185-90. PubMed ID: 21629979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [System biological approach to research and treatment of brain tumors].
    Shiraishi T; Tabuchi K; Kotani S; Konagaya A
    Tanpakushitsu Kakusan Koso; 2003 Jun; 48(7):795-801. PubMed ID: 12795192
    [No Abstract]   [Full Text] [Related]  

  • 16. Applicable advances in the molecular pathology of glioblastoma.
    Ranjit M; Motomura K; Ohka F; Wakabayashi T; Natsume A
    Brain Tumor Pathol; 2015 Jul; 32(3):153-62. PubMed ID: 26078107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: New Therapeutic Approaches for the Treatment of Glioblastoma.
    Festuccia C; Gravina GL
    Curr Cancer Drug Targets; 2017; 17(3):200-202. PubMed ID: 28322151
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences.
    Adachi Y; Chandrasekar N; Kin Y; Lakka SS; Mohanam S; Yanamandra N; Mohan PM; Fuller GN; Fang B; Fueyo J; Dinh DH; Olivero WC; Tamiya T; Ohmoto T; Kyritsis AP; Rao JS
    Oncogene; 2002 Jan; 21(1):87-95. PubMed ID: 11791179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics and malignant progression of human brain tumours.
    Furnari FB; Huang HJ; Cavenee WK
    Cancer Surv; 1995; 25():233-75. PubMed ID: 8718522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studying a complex tumor: potential and pitfalls.
    Zheng S; Chheda MG; Verhaak RG
    Cancer J; 2012; 18(1):107-14. PubMed ID: 22290264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.